Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis

Although biologic therapies have changed the course of rheumatoid arthritis (RA), today's major challenge remains to identify biomarkers to target treatments to selected patient groups. Circulating micro(mi)RNAs represent a novel class of molecular biomarkers whose expression is altered in RA....

Descripción completa

Detalles Bibliográficos
Autores principales: Duroux-Richard, Isabelle, Pers, Yves-Marie, Fabre, Sylvie, Ammari, Meryem, Baeten, Dominique, Cartron, Guillaume, Touitou, Isabelle, Jorgensen, Christian, Apparailly, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980876/
https://www.ncbi.nlm.nih.gov/pubmed/24778468
http://dx.doi.org/10.1155/2014/342524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980876/
https://www.ncbi.nlm.nih.gov/pubmed/24778468
http://dx.doi.org/10.1155/2014/342524

Ejemplares similares